RCUS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $24.44

Piyasa Değeri (MRQ) $3.10B

P/E (TTM) -6.3

Hisse Başına Kâr (TTM) $-3.89

Gelir (TTM) $117M

ROE (TTM) -90.8%

52 Haftlık Aralık $13–$32

RCUS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Arcus Biosciences, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriBiotechnology çalışanlar601 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$247M

2017-12-31 → 2025-12-31

Hisse Başına Kâr$-3.29

2019-12-31 → 2025-12-31

Serbest Nakit Akışı$-484M

2018-12-31 → 2025-12-31

Net kar marjı-393.2%

2018-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	RCUS	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-6.35Y ort. ≈7.0	≈7.0	·	·
F/S (TTM)	26.55Y ort. ≈10.1	≈10.1	28.1	Daha pahalı
F/D (MRQ)	6.75Y ort. ≈3.3	≈3.3	4.9	Aşırı değerli
Fiyat / Serbest Nakit Akışı (TTM)	-6.55Y ort. ≈-5.0	≈-5.0	·	·
Fiyat / Nakit Akışı (TTM)	-6.55Y ort. ≈-5.3	≈-5.3	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	4.95Y ort. ≈3.3	≈3.3	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	RCUS	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-415.4%5Y ort. ≈-162.1%	≈-162.1%	12.5%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-156.3%5Y ort. ≈-162.1%	≈-162.1%	12.5%	Zayıf
Vergi Öncesi Kar Marjı (TTM)	-393.2%5Y ort. ≈-146.5%	≈-146.5%	25.8%	Zayıf
Net Kâr Marjı (TTM)	-393.2%5Y ort. ≈-147.9%	≈-147.9%	10.9%	Zayıf
ROA (TTM)	-46.0%5Y ort. ≈-19.0%	≈-19.0%	-6.2%	Zayıf
ROE (TTM)	-90.8%5Y ort. ≈-41.6%	≈-41.6%	-7.0%	Zayıf
ROIC	-61.2%5Y ort. ≈-48.2%	≈-48.2%	-20.6%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	RCUS	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		3.85Y ort. ≈5.3	≈5.3	4.6	Düşük likidite
Quick Ratio (Cari Oran)		1.05Y ort. ≈0.9	≈0.9	4.4	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	RCUS	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	-4.3%5Y ort. ≈88.2%	≈88.2%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	30.2%5Y ort. ≈10.8%	≈10.8%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	25.9%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	RCUS	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-3.295Y ort. ≈$-2.72	≈$-2.72	·	·
Revenue / Share (Hisse Başına Gelir)	$2.305Y ort. ≈$2.70	≈$2.70	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-4.495Y ort. ≈$-1.58	≈$-1.58	·	·
Cash / Share (Hisse Başına Nakit)	$1.775Y ort. ≈$2.00	≈$2.00	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	5 Yıllık trend	RCUS	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)		0.25Y ort. ≈0.2	≈0.2	0.2	En üst düzey
Revenue / Employee (Çalışan Başına Gelir)		≈$411.0K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 19.8%

Sonraki Rapor Eki 26, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 12, 2026	$-0.72	$-0.92	21.4%
31 Mart 2026	May 12, 2026	$-1.02	$-0.89	-14.0%
31 Aralık 2025		$-0.89	$-1.05	15.0%
30 Eylül 2025		$-1.27	$-1.34	5.0%
30 Haziran 2025		$0.00	$-1.15	100.0%
31 Mart 2025		$-1.14	$-1.05	-8.4%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 14

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$247M	$258M	$117M	$112M	$383M	$78M	$15M	$8M	$1M
R&D Expense	$523M	$448M	$340M	$288M	$257M	$159M	$78M	$50M	$47M
SG&A Expense	$110M	$120M	$117M	$104M	$72M	$43M	$25M	$14M	$8M
Operating Expenses	$633M	$588M	$457M	$392M	$329M	$202M	$104M	$63M	$55M
Operating Income	$-386M	$-330M	$-340M	$-280M	$54M	$-124M	$-89M	$-55M	$-53M
Other Non-op	$33M	$48M	$39M	$14M	$1M	$1M	$4M	$5M	$359.0K
Pretax Income	$-353M	$-282M	$-301M	$-266M	$55M	$-123M	$-85M	·	·
Income Tax	$0	$1M	$6M	$1M	$2M	·	·	·	·
Net Income	$-353M	$-283M	$-307M	$-267M	$53M	$-123M	$-85M	$-50M	$-53M
EPS (Basic)	$-3.29	$-3.14	$-4.15	$-3.71	$0.76	$-2.24	$-1.93	·	·
EPS (Diluted)	$-3.29	$-3.14	$-4.15	$-3.71	$0.71	$-2.24	$-1.93	·	·
Shares (Basic)	107,400,000	90,100,000	74,000,000	72,000,000	69,300,000	54,800,000	43,825,991	36,357,336	3,885,508
Shares (Diluted)	107,400,000	90,100,000	74,000,000	72,000,000	74,000,000	54,800,000	43,825,991	·	·
EBITDA	$-386M	$-330M	$-340M	$-280M	$54M	$-124M	$-89M	$-55M	·

Bilanço 23

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$222M	$150M	$127M	$206M	$148M	$173M	$58M	$71M	$98M
Short-term Investments	·	·	·	·	·	$555M	$130M	$185M	$77M
Prepaid Expense	$15M	$18M	$34M	$19M	$18M	$5M	$4M	$2M	$1M
Current Assets	$1.01B	$1.02B	$831M	$1.07B	$1.26B	$736M	$193M	$259M	$177M
PP&E (Net)	$40M	$47M	$51M	$35M	$32M	$11M	$9M	$11M	$11M
PP&E (Gross)	$90M	$88M	$82M	$58M	$50M	$25M	$21M	$19M	$15M
Accum. Depreciation	$50M	$41M	$31M	$23M	$18M	$14M	$11M	$8M	$4M
Other Non-current Assets	$63M	$73M	$106M	$114M	$116M	$6M	$872.0K	$284.0K	$2M
Total Assets	$1.14B	$1.15B	$1.09B	$1.34B	$1.59B	$772M	$203M	$275M	$190M
Accounts Payable	$42M	$18M	$17M	$20M	$10M	$16M	$5M	$3M	$4M
Accrued Liabilities	·	·	·	·	$24M	$10M	$5M	$6M	$3M
Current Liabilities	$231M	$226M	$184M	$193M	$166M	$122M	$23M	$17M	$13M
Capital Leases	$86M	$99M	$110M	$117M	$117M	$15M	·	·	·
Other Non-current Liabilities	$135M	$157M	$142M	$140M	$122M	$543.0K	$806.0K	$2M	$565.0K
Total Liabilities	·	·	·	·	$750M	$270M	$39M	$40M	$37M
Long-term Debt	$99M	$48M	$0	·	·	·	·	·	·
Common Stock	$2.12B	$1.62B	$1.31B	$1.21B	$1.12B	$6.0K	$4.0K	$4.0K	·
Paid-in Capital	·	·	·	·	$1.12B	$830M	$369M	$358M	$948.0K
Retained Earnings	$-1.49B	$-1.13B	$-849M	$-542M	$-275M	$-328M	$-205M	$-123M	$-73M
AOCI	$0	·	$0	$-7M	$-1M	$44.0K	$64.0K	$-107.0K	$-42.0K
Stockholders' Equity	$631M	$485M	$462M	$657M	$842M	$502M	$164M	$235M	$-72M
Liabilities + Equity	$1.14B	$1.15B	$1.09B	$1.34B	$1.59B	$772M	$203M	$275M	$190M
Shares Outstanding	125,300,000	92,200,000	75,500,000	72,900,000	70,800,000	63,700,000	44,200,000	43,610,823	3,278,129

Nakit Akışı 12

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$10M	$10M	$8M	$6M	$4M	$3M	$4M	$4M	$3M
Stock-based Comp	$60M	$76M	$73M	$65M	$55M	$22M	$9M	$4M	$495.0K
Operating Cash Flow	$-482M	$-170M	$-306M	$438M	$-256M	$111M	$-73M	$-43M	$-25M
CapEx	$2M	$6M	$24M	$6M	$26M	$3M	$2M	$4M	$6M
Investing Cash Flow	$66M	$-84M	$194M	$-413M	$-4M	$-434M	$59M	$-113M	$-49M
Stock Issued	$429M	$228M	$25M	$0	$220M	$434M	$1M	$4M	·
Stock Repurchased	·	·	·	·	·	·	$94.0K	$0	·
Net Stock Activity	$429M	$228M	$25M	·	$220M	$434M	$1M	·	·
Financing Cash Flow	$488M	$277M	$33M	$33M	$237M	$439M	$1M	$129M	$107M
Net Change in Cash	$72M	$23M	$-79M	$58M	$-23M	$116M	$-13M	$-27M	$33M
Taxes Paid	$0	$0	$5M	·	·	·	·	·	·
Free Cash Flow	$-484M	$-176M	$-330M	$432M	$-282M	$108M	$-75M	$-47M	·

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-156.3%	-127.9%	-290.6%	-250.0%	14.2%	·	-591.4%	-656.8%	·
Net Margin	-142.9%	-109.7%	-262.4%	-238.4%	13.8%	·	-564.7%	-593.7%	·
Pretax Margin	-142.9%	-109.3%	-257.3%	-237.5%	14.3%	·	·	·	·
EBITDA Margin	-156.3%	-127.9%	-290.6%	-250.0%	14.2%	·	-591.4%	-656.8%	·
ROA	-30.8%	-25.2%	-25.2%	-18.2%	4.5%	-25.2%	-35.4%	-21.3%	·
ROE	-59.8%	-53.9%	-62.5%	-39.4%	7.6%	-23.5%	-49.7%	-20.7%	·
ROIC	-61.2%	-68.3%	-75.1%	-42.8%	6.2%	·	·	·	·

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio		4.4	4.5	4.5	5.5	7.6	6.0	8.5	15.3	·
Quick Ratio		1.0	0.7	0.7	1.1	0.9	6.0	8.3	15.1	·

Verimlilik 1

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		0.2	0.2	0.1	0.1	0.3	·	0.1	0.0	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$5.04	$5.26	$6.12	$9.01	$11.89	$7.71	$3.57	$5.28	·
Revenue / Share	$2.30	$2.86	$1.58	$1.56	$5.18	·	·	·	·
Cash Flow / Share	$-4.49	$-1.89	$-4.14	$6.08	$-3.46	·	·	·	·
Cash / Share	$1.77	$1.63	$1.68	$2.83	$2.09	$2.66	$1.26	$1.60	·
EPS (TTM)	$-3.29	$-3.14	$-4.15	$-3.71	$0.71	$-2.24	$-1.93	·	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-4.3%	120.5%	4.5%	-70.8%	391.0%	·	·	·	·
Revenue CAGR 3Y	30.2%	-12.3%	14.5%	·	·	·	·	·	·
Revenue CAGR 5Y	25.9%	·	·	·	·	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$247M	$258M	$117M	$112M	$383M	$78M	$15M	$8M	·
Net Income TTM	$-353M	$-283M	$-307M	$-267M	$53M	$-123M	$-85M	$-50M	·
Market Cap	$2.99B	$1.37B	$1.44B	$1.51B	$2.86B	$1.69B	$464M	$480M	·
P/E	-7.2	-4.7	-4.6	-5.6	57.0	-11.6	-5.2	·	·
P/S	12.1	5.3	12.3	13.5	7.5	21.7	30.9	57.4	·
P/B	4.7	2.8	3.1	2.3	3.4	3.4	2.8	2.0	·
P / Tangible Book	4.7	2.8	3.1	2.3	3.4	3.4	·	·	·
P / Cash Flow	-6.2	-8.1	-4.7	3.4	-11.2	15.2	-6.3	-11.2	·
P / FCF	-6.2	-7.8	-4.4	3.5	-10.1	15.6	-6.2	-10.3	·
Earnings Yield	-13.8%	-21.1%	-21.7%	-17.9%	1.8%	-8.6%	-19.1%	·	·

Gelir Tablosu 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$41M	$17M	$33M	$26M	$160M	$28M	$26M	$48M	$39M	$145M	$31M	$32M	$29M	$25M	$34M	$33M
R&D Expense	$113M	$122M	$121M	$141M	$139M	$122M	$101M	$123M	$115M	$109M	$93M	$82M	$84M	$81M	$80M	$77M
SG&A Expense	$24M	$29M	$26M	$27M	$29M	$28M	$28M	$30M	$30M	$32M	$29M	$30M	$28M	$30M	$28M	$26M
Operating Expenses	$137M	$151M	$147M	$168M	$168M	$150M	$129M	$153M	$145M	$161M	$122M	$112M	$112M	$111M	$108M	$103M
Operating Income	$-96M	$-134M	$-114M	$-142M	$-8M	$-122M	$-103M	$-105M	$-106M	$-16M	$-91M	$-80M	$-83M	$-86M	$-74M	$-70M
Other Non-op	$5M	$6M	$8M	$7M	$8M	$10M	$10M	$13M	$13M	$12M	$11M	$11M	$9M	$8M	$7M	$5M
Pretax Income	$-91M	$-128M	$-106M	$-135M	$0	$-112M	$-93M	$-92M	$-93M	$-4M	$-80M	$-69M	$-74M	$-78M	$-67M	$-65M
Income Tax	$0	$0	$0	$0	$0	$0	$1M	$0	$0	$0	$1M	$2M	$1M	$2M	$0	$0
Net Income	$-91M	$-128M	$-106M	$-135M	$0	$-112M	$-94M	$-92M	$-93M	$-4M	$-81M	$-71M	$-75M	$-80M	$-67M	$-65M
EPS (Basic)	$-0.72	$-1.02	$-0.88	$-1.27	$0.00	$-1.14	$-1.07	$-1.00	$-1.02	$-0.05	$-1.08	$-0.94	$-1.04	$-1.09	$-0.93	$-0.90
EPS (Diluted)	$-0.72	$-1.02	$-0.88	$-1.27	$0.00	$-1.14	$-1.07	$-1.00	$-1.02	$-0.05	$-1.08	$-0.94	$-1.04	$-1.09	$-0.93	$-0.90
Shares (Basic)	126,100,000	125,400,000	·	106,500,000	106,100,000	98,400,000	·	91,400,000	91,100,000	86,200,000	·	74,600,000	73,200,000	73,000,000	·	72,200,000
Shares (Diluted)	126,100,000	125,400,000	·	106,500,000	106,500,000	98,400,000	·	91,400,000	91,100,000	86,200,000	·	74,600,000	73,200,000	73,000,000	·	72,200,000
EBITDA	$-96M	$-134M	·	$-142M	$-8M	$-122M	·	$-105M	$-106M	$-16M	·	$-80M	$-83M	$-86M	·	$-69M

Bilanço 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$150M	$201M	$222M	$238M	$248M	$192M	$150M	$201M	$156M	$185M	·	$184M	$230M	$238M	·	$218M
Prepaid Expense	$18M	$19M	$15M	$15M	$20M	$19M	$18M	$22M	$25M	$34M	·	$31M	$22M	$28M	·	$22M
Current Assets	$756M	$844M	$1.01B	$857M	$946M	$1.03B	$1.02B	$1.13B	$1.02B	$1.06B	·	$882M	$986M	$1.01B	·	$1.10B
PP&E (Net)	$36M	$38M	$40M	$42M	$44M	$46M	$47M	$48M	$49M	$51M	·	$50M	$45M	$37M	·	$34M
PP&E (Gross)	·	·	$90M	·	·	·	$88M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$50M	·	·	·	$41M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$59M	$61M	$63M	$65M	$69M	$71M	$73M	$75M	$75M	$78M	·	$108M	$109M	$112M	·	$11M
Total Assets	$924M	$997M	$1.14B	$974M	$1.07B	$1.16B	$1.15B	$1.25B	$1.19B	$1.29B	·	$1.19B	$1.22B	$1.25B	·	$1.39B
Accounts Payable	$34M	$39M	$42M	$42M	$29M	$22M	$18M	$13M	$15M	$16M	·	$17M	$12M	$28M	·	$11M
Accrued Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$21M
Current Liabilities	$198M	$209M	$231M	$235M	$210M	$192M	$226M	$215M	$199M	$204M	·	$200M	$180M	$179M	·	$177M
Capital Leases	·	·	$86M	·	·	·	$99M	·	·	·	·	·	·	·	·	$119M
Other Non-current Liabilities	$124M	$119M	$135M	$152M	$159M	$166M	$157M	$136M	$138M	$140M	·	$145M	$144M	$145M	·	$16M
Total Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$695M
Long-term Debt	$101M	$100M	$99M	$98M	$97M	$48M	$48M	$47M	·	·	·	·	·	·	·	·
Common Stock	$2.17B	$2.14B	$2.12B	$1.81B	$1.79B	$1.77B	$1.62B	$1.60B	$1.58B	$1.56B	·	$1.29B	$1.27B	$1.23B	·	$7.0K
Paid-in Capital	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$1.18B
Retained Earnings	$-1.70B	$-1.61B	$-1.49B	$-1.38B	$-1.24B	$-1.24B	$-1.13B	$-1.04B	$-946M	$-853M	·	$-768M	$-697M	$-622M	·	$-475M
AOCI	$-1M	$-1M	·	·	·	·	·	$1M	$-1M	$-1M	·	$-3M	$-4M	$-4M	·	$-10M
Stockholders' Equity	$464M	$524M	$631M	$436M	$549M	$531M	$485M	$565M	$635M	$707M	$462M	$520M	$566M	$600M	$657M	$699M
Liabilities + Equity	$924M	$997M	$1.14B	$974M	$1.07B	$1.16B	$1.15B	$1.25B	$1.19B	$1.29B	·	$1.19B	$1.22B	$1.25B	·	$1.39B
Shares Outstanding	127,000,000	125,500,000	125,300,000	107,100,000	106,400,000	105,900,000	92,200,000	91,500,000	91,300,000	90,900,000	75,500,000	74,800,000	74,500,000	73,100,000	72,900,000	72,352,380

Nakit Akışı 10

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$2M	$3M	$2M	$2M	$3M	$3M	$2M	$2M	$3M	$3M	$1M	$2M	$2M	$1M	$2M
Stock-based Comp	$15M	$19M	$15M	$14M	$15M	$16M	$17M	$19M	$20M	$20M	$18M	$18M	$18M	$19M	$17M	$16M
Operating Cash Flow	$-119M	$-138M	$-120M	$-97M	$-133M	$-132M	$-100M	$26M	$-94M	$-2M	$-88M	$-63M	$-57M	$-98M	$-70M	$-81M
CapEx	$0	$0	$1M	$0	$0	$1M	$1M	$1M	$0	$4M	$6M	$10M	$5M	$3M	$0	$2M
Investing Cash Flow	$52M	$114M	$-182M	$79M	$137M	$32M	$51M	$-29M	$63M	$-169M	$28M	$11M	$26M	$129M	$47M	$23M
Stock Issued	$0	$0	$279M	$8M	$0	$142M	$0	$0	$0	$228M	$0	$5M	$20M	$0	$0	·
Net Stock Activity	·	$0	·	·	·	$142M	·	·	·	$228M	·	·	·	·	·	·
Financing Cash Flow	$16M	$3M	$286M	$8M	$52M	$142M	$-2M	$48M	$2M	$229M	$3M	$6M	$23M	$1M	$11M	$3M
Net Change in Cash	$-51M	$-21M	$-16M	$-10M	$56M	$42M	$-51M	$45M	$-29M	$58M	$-57M	$-46M	$-8M	$32M	$-12M	$-55M
Free Cash Flow	·	$-138M	·	·	·	$-133M	·	·	·	$-6M	·	·	·	$-101M	·	·

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-234.1%	-788.2%	·	-546.1%	-5.0%	-435.7%	·	-218.8%	-271.8%	-11.0%	·	-250.0%	-286.2%	-344.0%	·	-206.7%
Net Margin	-221.9%	-752.9%	·	-519.2%	0.00%	-400.0%	·	-191.7%	-238.5%	-2.8%	·	-221.9%	-258.6%	-320.0%	·	-193.3%
Pretax Margin	-221.9%	-752.9%	·	-519.2%	0.00%	-400.0%	·	-191.7%	-238.5%	-2.8%	·	-215.6%	-255.2%	-312.0%	·	-193.3%
EBITDA Margin	-234.1%	-788.2%	·	-546.1%	-5.0%	-435.7%	·	-218.8%	-271.8%	-11.0%	·	-250.0%	-286.2%	-344.0%	·	-206.7%
ROA	-9.1%	-11.9%	·	-12.1%	0.00%	-9.2%	·	-7.5%	-7.7%	-0.31%	·	-5.5%	-5.6%	-5.7%	·	-5.8%
ROE	-18.0%	-24.3%	·	-27.0%	0.00%	-18.1%	·	-17.0%	-15.5%	-0.61%	·	-11.7%	-11.4%	-11.5%	·	-10.5%
ROIC	-20.7%	-25.6%	·	-32.6%	·	-23.0%	·	-18.6%	-16.7%	-2.3%	·	-15.8%	-14.9%	-14.7%	·	-9.9%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		3.8	4.0	·	3.6	4.5	5.4	·	5.2	5.1	5.2	·	4.4	5.5	5.7	·	6.2
Quick Ratio		0.8	1.0	·	1.0	1.2	1.0	·	0.9	0.8	0.9	·	0.9	1.3	1.3	·	1.2

Verimlilik 1

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.1	0.0	·	0.0	0.0	0.1	·	0.0	0.0	0.0	·	0.0

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.65	$4.18	·	$4.07	$5.16	$5.01	·	$6.17	$6.96	$7.78	·	$6.95	$7.60	$8.21	·	$9.66
Revenue / Share	$0.33	$0.14	·	$0.24	$1.50	$0.28	·	$0.53	$0.43	$1.68	·	$0.43	$0.40	$0.34	·	$0.46
Cash Flow / Share	·	$-1.10	·	·	·	$-1.34	·	·	·	$-0.02	·	·	·	$-1.34	·	·
Cash / Share	$1.18	$1.60	·	$2.22	$2.33	$1.81	·	$2.20	$1.71	$2.04	·	$2.46	$3.09	$3.26	·	$3.01
EPS (TTM)	$-3.89	$-3.17	·	$-3.48	$-3.21	$-4.23	·	$-3.15	$-3.09	$-3.11	·	$-4.00	$-3.96	·	·	·

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$117M	$236M	·	$240M	$262M	$141M	·	$263M	$247M	$237M	·	$120M	$121M	$119M	·	$433M
Net Income TTM	$-460M	$-369M	·	$-341M	$-298M	$-391M	·	$-270M	$-249M	$-231M	·	$-293M	$-287M	$-279M	·	$80M
Market Cap	$3.92B	$2.71B	·	$1.46B	$866M	$831M	·	$1.40B	$1.39B	$1.72B	·	$1.34B	$1.51B	$1.33B	·	$1.89B
P/E	-7.9	-6.8	·	-3.9	-2.5	-1.9	·	-4.9	-4.9	-6.1	·	-4.5	-5.1	·	·	·
P/S	33.5	11.5	·	6.1	3.3	5.9	·	5.3	5.6	7.2	·	11.2	12.5	11.2	·	4.4
P/B	8.4	5.2	·	3.3	1.6	1.6	·	2.5	2.2	2.4	·	2.6	2.7	2.2	·	2.7
P / Tangible Book	8.4	5.2	·	3.3	1.6	1.6	·	2.5	2.2	2.4	·	2.6	2.7	2.2	·	2.7
P / Cash Flow	·	-19.6	·	·	·	-6.3	·	·	·	-858.1	·	·	·	-13.6	·	·
Earnings Yield	-12.6%	-14.7%	·	-25.6%	-39.4%	-53.9%	·	-20.6%	-20.3%	-16.5%	·	-22.3%	-19.5%	·	·	·

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$247M	$258M	$117M	$112M	$383M
Faaliyet Kâr Marjı %	-156.3%	-127.9%	-290.6%	-250.0%	14.2%
Net Gelir	$-353M	$-283M	$-307M	$-267M	$53M
Seyreltilmiş Hisse Başı Kâr	$-3.29	$-3.14	$-4.15	$-3.71	$0.71

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	4.4	4.5	4.5	5.5	7.6
Cari Oran	1.0	0.7	0.7	1.1	0.9

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-484M	$-176M	$-330M	$432M	$-282M

Kurumsal Sahipler (13F) 243 dosya · $4.0B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 243

Tutulan Değer $4.0B

Yeni pozisyonlar 46

Çıkan pozisyonlar 23

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
46 (+5 önceki Ç'ye göre)	23 (-8 önceki Ç'ye göre)	86 (+2 önceki Ç'ye göre)	64 (+4 önceki Ç'ye göre)	+4.3M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
GILEAD SCIENCES, INC.	$968.825.351	31.424.760	24,50%	Hisse senetleri
BlackRock, Inc.	$506.112.958	16.416.249	12,80%	Hisse senetleri
VANGUARD GROUP INC	$189.755.288	7.962.874	4,80%	Hisse senetleri
STATE STREET CORP	$185.888.992	6.029.484	4,70%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$181.756.661	5.895.448	4,60%	Hisse senetleri
MONTANOVA CAPITAL, LLC	$147.257.121	4.776.423	3,72%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$137.980.528	4.475.528	3,49%	Hisse senetleri
FMR LLC	$124.854.021	4.049.757	3,16%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$119.877.707	3.888.346	3,03%	Hisse senetleri
CITADEL ADVISORS LLC	$96.653.807	3.135.057	2,44%	Hisse senetleri
Woodline Partners LP	$92.730.412	3.007.798	2,35%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$75.507.790	2.448.749	1,91%	Hisse senetleri
Siren, L.L.C.	$74.621.857	2.420.430	1,89%	Hisse senetleri
Fisher Asset Management, LLC	$65.957.578	2.139.396	1,67%	Hisse senetleri
MARSHALL WACE, LLP	$59.967.064	1.945.088	1,52%	Hisse senetleri
SAMLYN CAPITAL, LLC	$47.699.621	1.547.182	1,21%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$44.221.943	1.434.320	1,12%	Hisse senetleri
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$43.764.202	1.419.533	1,11%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$42.778.660	1.387.566	1,08%	Hisse senetleri
Soleus Capital Management, L.P.	$36.032.193	1.168.738	0,91%	Hisse senetleri
Sofinnova Investments, Inc.	$29.155.623	945.690	0,74%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$29.034.337	941.756	0,73%	Hisse senetleri
NORTHERN TRUST CORP	$28.749.685	932.523	0,73%	Hisse senetleri
Parkman Healthcare Partners LLC	$28.340.971	919.266	0,72%	Hisse senetleri
Invesco Ltd.	$26.058.533	845.233	0,66%	Hisse senetleri
BAKER BROS. ADVISORS LP	$26.045.677	844.816	0,66%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$25.758.589	835.504	0,65%	Hisse senetleri
MORGAN STANLEY	$24.537.986	795.912	0,62%	Hisse senetleri
Candriam S.C.A.	$20.389.238	661.981	0,52%	Hisse senetleri
Aberdeen Group plc	$20.061.451	650.712	0,51%	Hisse senetleri
Logos Global Management LP	$20.039.500	650.000	0,51%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$19.589.505	635.404	0,50%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$18.993.993	616.088	0,48%	Hisse senetleri
Bank of New York Mellon Corp	$16.740.979	543.009	0,42%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$15.787.550	512.084	0,40%	Hisse senetleri
Ikarian Capital, LLC	$15.555.555	504.559	0,39%	Hisse senetleri
Decheng Capital LLC	$14.329.137	464.779	0,36%	Hisse senetleri
DAFNA Capital Management LLC	$13.621.588	441.829	0,34%	Hisse senetleri
JPMORGAN CHASE & CO	$13.121.105	418.243	0,33%	Hisse senetleri
PRINCIPAL FINANCIAL GROUP INC	$13.052.373	423.366	0,33%	Hisse senetleri
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$11.688.000	379.100	0,30%	Hisse senetleri
UBS Group AG	$11.377.996	369.056	0,29%	Hisse senetleri
Patient Square Capital LP	$10.969.314	355.800	0,28%	Hisse senetleri
PDT Partners, LLC	$9.975.571	323.567	0,25%	Hisse senetleri
Public Sector Pension Investment Board	$9.192.149	298.156	0,23%	Hisse senetleri
FIRST TRUST ADVISORS LP	$8.368.310	271.434	0,21%	Hisse senetleri
Nuveen, LLC	$7.215.824	234.052	0,18%	Hisse senetleri
Connor, Clark & Lunn Investment Management Ltd.	$6.936.997	225.008	0,18%	Hisse senetleri
DIADEMA PARTNERS LP	$6.900.062	223.810	0,17%	Hisse senetleri
RHUMBLINE ADVISERS	$6.757.319	219.181	0,17%	Hisse senetleri

Tüm 243 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 3 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Gilead Sciences, Inc.	07 Ağustos 2026	24,70%	Değişiklik	·	SEC
Terry Rosen, Ph.D. ×2 başvurular	17 Aralık 2024	·	İlk başvuru	·	SEC
Juan Jaen, Ph.D., Anita Galeana, Juan Carlos Jaen and Anita Galeana 2000 Trust ×2 başvurular	15 Ekim 2020	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 23 içeriden öğrenenler · 12 yöneticiler · 10 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Terry J Rosen	Chief Executive Officer	23 Ocak 2026 A	2.236.409	2	$-1.203.847
Ii Robert C. Goeltz	Chief Financial Officer	11 Mayıs 2026 S	84.161	6	$-855.866
Rekha Hemrajani	Chief Operating Officer and Chief Financial Officer	25 Mart 2019 A	·	0	$0
Juan C. Jaen	President	10 Temmuz 2026 S	822.240	21	$-9.219.575
Jennifer Jarrett	Chief Operating Officer	23 Ocak 2026 A	224.024	5	$-2.171.366
Alexander Azoy	Chief Accounting Officer	21 Ağustos 2026 M	39.581	6	$-395.676
Carolyn C. Tang	General Counsel	11 Haziran 2026 M	184.607	2	$-318.467
Richard Markus	Chief Medical Officer	23 Ocak 2026 A	89.647	2	$-210.125
Nuyten Dimitry SA	Chief Medical Officer	15 Aralık 2024 F	87.518	0	$0
William Grossman	Chief Medical Officer	17 Haziran 2021 S	20.723	0	$0
Jason Barker	VP Finance; Principal Financial and Accounting Officer	04 Haziran 2020 A	10.000	0	$0
Steven Chan	Principal Financial and Accounting Officer	16 Ocak 2019 A	·	0	$0
Antoni Ribas	Yönetim kurulu üyesi	11 Haziran 2026 A	44.300	0	$0
Nicole Lambert	Yönetim kurulu üyesi	11 Haziran 2026 A	43.000	0	$0
David L. Lacey	Yönetim kurulu üyesi	11 Haziran 2026 A	76.652	0	$0
Patrick Machado	Yönetim kurulu üyesi	11 Haziran 2026 A	44.300	0	$0
Yasunori Kaneko	Yönetim kurulu üyesi	11 Haziran 2026 A	25.700	0	$0
Kathryn E Falberg	Yönetim kurulu üyesi	11 Haziran 2026 A	44.300	0	$0
Andrew J Perlman	Yönetim kurulu üyesi	11 Haziran 2026 A	48.325	0	$0
Kristen Hege	Yönetim kurulu üyesi	06 Haziran 2019 A	·	0	$0
David W Beier	Yönetim kurulu üyesi	06 Haziran 2019 A	·	0	$0
Gilead Sciences, Inc.	10% sahip	18 Şubat 2025 P	31.424.760	0	$0
Hadley Harbor Master Investors (Cayman) II L.P.	10% sahip	19 Mart 2018 C	1.496.813	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 56 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IDNA · iShares Trust	2,13%	207.943 SH	11 Eylül 2026	Günlük
PSCH · Invesco Exchange-Traded Fund Trust …	1,26%	86.868 SH	01 Ekim 2026	Günlük
BBC · ETFis Series Trust I	0,79%	13.060 NS	31 Temmuz 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,78%	864.538 SH	01 Ekim 2026	Günlük
FYC · First Trust Exchange-Traded AlphaDE…	0,62%	284.644 NS	31 Temmuz 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,50%	87.676 NS	31 Temmuz 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,44%	69.039 SH	01 Ekim 2026	Günlük
JDOC · J.P. Morgan Exchange-Traded Fund Tr…	0,43%	1.384 NS	31 Temmuz 2026	N-PORT
FYX · First Trust Exchange-Traded AlphaDE…	0,23%	113.180 NS	31 Temmuz 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,19%	121.164 SH	19 Ağustos 2026	Günlük
VIOG · VANGUARD ADMIRAL FUNDS	0,18%	65.077 SH	19 Ağustos 2026	Günlük
IBB · iShares Trust	0,16%	639.708 SH	11 Eylül 2026	Günlük
QVMS · Invesco Exchange-Traded Fund Trust …	0,15%	13.473 SH	01 Ekim 2026	Günlük
PWS · Pacer Funds Trust	0,14%	1.198 NS	31 Temmuz 2026	N-PORT
VIOO · VANGUARD ADMIRAL FUNDS	0,14%	303.431 SH	19 Ağustos 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,13%	75.323 SH	19 Ağustos 2026	Günlük
FAD · First Trust Exchange-Traded AlphaDE…	0,13%	25.784 NS	31 Temmuz 2026	N-PORT
IWO · iShares Trust	0,12%	658.371 SH	11 Eylül 2026	Günlük
VIOV · VANGUARD ADMIRAL FUNDS	0,11%	68.135 SH	19 Ağustos 2026	Günlük
BKSE · BNY Mellon ETF Trust	0,11%	3.277 NS	31 Temmuz 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,09%	22.969 NS	31 Temmuz 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	90.886 SH	01 Ekim 2026	Günlük
RSSL · Global X Funds	0,08%	42.828 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,08%	514.877 SH	19 Ağustos 2026	Günlük
IWM · iShares Trust	0,08%	2.296.266 SH	11 Eylül 2026	Günlük
ESML · iShares Trust	0,06%	61.466 SH	11 Eylül 2026	Günlük
DFAS · Dimensional ETF Trust	0,05%	273.376 NS	31 Temmuz 2026	N-PORT
TECB · iShares Trust	0,04%	8.223 SH	11 Eylül 2026	Günlük
SMDX · Tidal Trust III	0,04%	1.986 NS	31 Temmuz 2026	N-PORT
VBK · VANGUARD INDEX FUNDS	0,04%	586.542 SH	19 Ağustos 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	16.721 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,04%	264.113 SH	19 Ağustos 2026	Günlük
FHLC · FIDELITY COVINGTON TRUST	0,04%	41.576 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.000.271 SH	19 Ağustos 2026	Günlük
ISCG · iShares Trust	0,03%	10.730 SH	11 Eylül 2026	Günlük
VB · VANGUARD INDEX FUNDS	0,02%	1.011.587 SH	19 Ağustos 2026	Günlük
WSML · iShares Trust	0,02%	5.013 SH	11 Eylül 2026	Günlük
TILT · FlexShares Trust	0,01%	6.162 NS	31 Temmuz 2026	N-PORT
RWJ · Invesco Exchange-Traded Fund Trust …	0,01%	5.338 SH	01 Ekim 2026	Günlük
ITOT · iShares Trust	0,00%	124.162 SH	11 Eylül 2026	Günlük
DCOR · Dimensional ETF Trust	0,00%	3.906 NS	31 Temmuz 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	12.625 NS	31 Temmuz 2026	N-PORT
IWV · iShares Trust	0,00%	21.339 SH	11 Eylül 2026	Günlük
DFAC · Dimensional ETF Trust	0,00%	11.946 NS	31 Temmuz 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	2.340 NS	31 Temmuz 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	2.799.235 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.495 SH	19 Ağustos 2026	Günlük
IJR · iShares Trust	·	5.294.319 SH	10 Eylül 2026	Günlük
IJT · iShares Trust	·	517.549 SH	09 Eylül 2026	Günlük
IJS · iShares Trust	·	287.856 SH	08 Eylül 2026	Günlük
IWN · iShares Trust	·	185.987 SH	11 Eylül 2026	Günlük
XJR · iShares Trust	·	11.976 SH	31 Ağustos 2026	Günlük
ISCB · iShares Trust	·	3.839 SH	11 Eylül 2026	Günlük
ISCV · iShares Trust	·	11.367 SH	11 Eylül 2026	Günlük
SMLF · iShares Trust	·	99.950 SH	11 Eylül 2026	Günlük
SMMV · iShares Trust	·	4.789 SH	01 Eylül 2026	Günlük

RCUS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 19 analist AL

Medyan hedef $43.00 +75,9%

5 26,3% Güçlü Al

10 52,6% Al

4 21,1% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

11 analist · 2026-09-30

Ortalama hedef $39.91 +63,3%

Şimdi Mevcut fiyat $24.44

Düşük$23.00 Ortalama$39.91 Yüksek$47.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
RCUS	$2.99B	-7.2	-4.3%	-142.9%	-59.8%	·
CELC	$4.81B	-26.3	·	·	-244.3%	·
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	·
ACAD	$4.55B	11.6	11.9%	36.5%	38.1%	·
DNLI	$2.58B	-5.6	204.7%	·	-50.2%	·
ARQT	$3.58B	-223.4	91.3%	-4.3%	-9.8%	·
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	·
DYN	$3.23B	-5.6	·	·	-57.8%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

RCUS Arcus Biosciences, Inc. Common Stock